Skip to main content

Table 1 Patient characteristics of the study population

From: Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

Characteristic

Median

Percentage/range

Age (years)

62.2

36–82

Initial CA-125 level (U/mL)

920

41–24440

CA-125 decreasing kinetics

2.2

0.9–28.6

Tumor sites a

  < = 3

38

23.7%

  > 3

122

76.3%

Preoperative ascites

  < 500 ml

88

55.0%

  > =500 ml

72

45.0%

Surgical residual

 No macroscopic focus

129

80.6%

 1–2 cm

6

3.8%

  > 2 cm

23

14.4%

 Unknown

2

1.3%

FIGO stage b

 IIIc

133

83.1%

 IV

27

16.9%

  1. Tumor sites a abdomen is divided into four quadrants according to the belly button
  2. FIGO b the International Federation of Gynecology and Obstetrics